Detalhe da pesquisa
1.
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).
Cephalalgia
; 40(3): 241-254, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32075406
2.
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.
J Headache Pain
; 21(1): 120, 2020 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023473
3.
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.
Cephalalgia
; 39(9): 1075-1085, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31234642
4.
The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia.
BMC Psychiatry
; 18(1): 24, 2018 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378547
5.
VISTA: A µ-Thermogravimeter for Investigation of Volatile Compounds in Planetary Environments.
Orig Life Evol Biosph
; 46(2-3): 273-81, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26603435
6.
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
Cephalalgia
; 31(1): 18-30, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20974598
7.
Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients.
Pain Res Manag
; 16(4): 245-51, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22059194
8.
Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine.
Front Immunol
; 12: 765822, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34759933
9.
Carisbamate in essential tremor: brief report of a proof of concept study.
Mov Disord
; 25(5): 634-8, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20201005
10.
Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.
Headache
; 50(5): 795-807, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20546320
11.
Electronic medical records as a research tool: evaluating topiramate use at a headache center.
Headache
; 50(5): 769-78, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20236335
12.
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.
Neurology
; 94(13): e1365-e1377, 2020 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209650
13.
Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Clin Ther
; 31(3): 542-59, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19393844
14.
Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
Headache
; 49(3): 350-63, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19220503
15.
Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.
Headache
; 48(7): 1087-95, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18687081
16.
An update on migraine pathophysiology and mechanism-based pharmacotherapeutics for migraine.
Postgrad Med
; Spec No: 5-13, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17960686
17.
Cervicogenic headache: a review of diagnostic and treatment strategies.
J Am Osteopath Assoc
; 105(4 Suppl 2): 16S-22S, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15928349
18.
Tolerability and efficacy of tapentadol extended release in elderly patients ≥ 75 years of age with chronic osteoarthritis knee or low back pain.
J Opioid Manag
; 11(5): 393-403, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26535967
19.
Validation of the Hospital Anxiety and Depression Scale in Patients With Acute Low Back Pain.
J Pain
; 16(10): 1012-21, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26208762
20.
Validation of the Short-form McGill Pain Questionnaire-2 (SF-MPQ-2) in acute low back pain.
J Pain
; 16(4): 357-66, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25640290